Cost-Effectiveness Analysis of the Introduction of HPV Vaccination of 9-Year-Old-Girls in Iran
ConclusionsIntroducing a three-dose HPV vaccination program is currently not cost-effective in Iran. Because vaccine supplies cost is the most important parameter in this evaluation, considering a two-dose schedule or reducing vaccine prices has an impact on final conclusions.
Source: Value in Health Regional Issues - Category: International Medicine & Public Health Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Disability | Epidemiology | Genital Warts | Girls | Human Papillomavirus (HPV) | Iran Health | Middle East Health | Vaccines